Literature DB >> 18846255

Calsarcin-2 deficiency increases exercise capacity in mice through calcineurin/NFAT activation.

Norbert Frey1, Derk Frank, Stefanie Lippl, Christian Kuhn, Harald Kögler, Tomasa Barrientos, Claudia Rohr, Rainer Will, Oliver J Müller, Hartmut Weiler, Rhonda Bassel-Duby, Hugo A Katus, Eric N Olson.   

Abstract

The composition of skeletal muscle, in terms of the relative number of slow- and fast-twitch fibers, is tightly regulated to enable an organism to respond and adapt to changing physical demands. The phosphatase calcineurin and its downstream targets, transcription factors of the nuclear factor of activated T cells (NFAT) family, play a critical role in this process by promoting the formation of slow-twitch, oxidative fibers. Calcineurin binds to calsarcins, a family of striated muscle-specific proteins of the sarcomeric Z-disc. We show here that mice deficient in calsarcin-2, which is expressed exclusively by fast-twitch muscle and encoded by the myozenin 1 (Myoz1) gene, have substantially reduced body weight and fast-twitch muscle mass in the absence of an overt myopathic phenotype. Additionally, Myoz1 KO mice displayed markedly improved performance and enhanced running distances in exercise studies. Analysis of fiber type composition of calsarcin-2-deficient skeletal muscles showed a switch toward slow-twitch, oxidative fibers. Reporter assays in cultured myoblasts indicated an inhibitory role for calsarcin-2 on calcineurin, and Myoz1 KO mice exhibited both an excess of NFAT activity and an increase in expression of regulator of calcineurin 1-4 (RCAN1-4), indicating enhanced calcineurin signaling in vivo. Taken together, these results suggest that calsarcin-2 modulates exercise performance in vivo through regulation of calcineurin/NFAT activity and subsequent alteration of the fiber type composition of skeletal muscle.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18846255      PMCID: PMC2564612          DOI: 10.1172/JCI36277

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  42 in total

1.  Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles.

Authors:  J Yang; B Rothermel; R B Vega; N Frey; T A McKinsey; E N Olson; R Bassel-Duby; R S Williams
Journal:  Circ Res       Date:  2000-12-08       Impact factor: 17.367

2.  Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway.

Authors:  H Wu; B Rothermel; S Kanatous; P Rosenberg; F J Naya; J M Shelton; K A Hutcheson; J M DiMaio; E N Olson; R Bassel-Duby; R S Williams
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

Review 3.  NFAT signaling: choreographing the social lives of cells.

Authors:  Gerald R Crabtree; Eric N Olson
Journal:  Cell       Date:  2002-04       Impact factor: 41.582

4.  A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.

Authors:  U Delling; J Tureckova; H W Lim; L J De Windt; P Rotwein; J D Molkentin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

5.  Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins.

Authors:  Norbert Frey; Eric N Olson
Journal:  J Biol Chem       Date:  2002-02-12       Impact factor: 5.157

6.  Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo.

Authors:  F J Naya; B Mercer; J Shelton; J A Richardson; R S Williams; E N Olson
Journal:  J Biol Chem       Date:  2000-02-18       Impact factor: 5.157

7.  Calsarcins, a novel family of sarcomeric calcineurin-binding proteins.

Authors:  N Frey; J A Richardson; E N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

8.  Regulation of mitochondrial biogenesis in skeletal muscle by CaMK.

Authors:  Hai Wu; Shane B Kanatous; Frederick A Thurmond; Teresa Gallardo; Eiji Isotani; Rhonda Bassel-Duby; R Sanders Williams
Journal:  Science       Date:  2002-04-12       Impact factor: 47.728

9.  Myozenin: an alpha-actinin- and gamma-filamin-binding protein of skeletal muscle Z lines.

Authors:  F Takada; D L Vander Woude; H Q Tong; T G Thompson; S C Watkins; L M Kunkel; A H Beggs
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-06       Impact factor: 11.205

10.  FATZ, a filamin-, actinin-, and telethonin-binding protein of the Z-disc of skeletal muscle.

Authors:  G Faulkner; A Pallavicini; A Comelli; M Salamon; G Bortoletto; C Ievolella; S Trevisan; S Kojic'; F Dalla Vecchia; P Laveder; G Valle; G Lanfranchi
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

View more
  58 in total

1.  FGF23 induces left ventricular hypertrophy.

Authors:  Christian Faul; Ansel P Amaral; Behzad Oskouei; Ming-Chang Hu; Alexis Sloan; Tamara Isakova; Orlando M Gutiérrez; Robier Aguillon-Prada; Joy Lincoln; Joshua M Hare; Peter Mundel; Azorides Morales; Julia Scialla; Michael Fischer; Elsayed Z Soliman; Jing Chen; Alan S Go; Sylvia E Rosas; Lisa Nessel; Raymond R Townsend; Harold I Feldman; Martin St John Sutton; Akinlolu Ojo; Crystal Gadegbeku; Giovana Seno Di Marco; Stefan Reuter; Dominik Kentrup; Klaus Tiemann; Marcus Brand; Joseph A Hill; Orson W Moe; Makoto Kuro-O; John W Kusek; Martin G Keane; Myles Wolf
Journal:  J Clin Invest       Date:  2011-10-10       Impact factor: 14.808

Review 2.  Regulation of exercise-induced fiber type transformation, mitochondrial biogenesis, and angiogenesis in skeletal muscle.

Authors:  Zhen Yan; Mitsuharu Okutsu; Yasir N Akhtar; Vitor A Lira
Journal:  J Appl Physiol (1985)       Date:  2010-10-28

3.  The nuclear receptor, Nor-1, markedly increases type II oxidative muscle fibers and resistance to fatigue.

Authors:  Michael A Pearen; Natalie A Eriksson; Rebecca L Fitzsimmons; Joel M Goode; Nick Martel; Sofianos Andrikopoulos; George E O Muscat
Journal:  Mol Endocrinol       Date:  2012-01-26

4.  Post-translational regulation of calsarcin-1 during pressure overload-induced cardiac hypertrophy.

Authors:  Anna K Paulsson; Sarah Franklin; Scherise A Mitchell-Jordan; Shuxun Ren; Yibin Wang; Thomas M Vondriska
Journal:  J Mol Cell Cardiol       Date:  2010-02-17       Impact factor: 5.000

Review 5.  Genomics and genetics in the biology of adaptation to exercise.

Authors:  Claude Bouchard; Tuomo Rankinen; James A Timmons
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

6.  The Effect of ACTN3 Gene Doping on Skeletal Muscle Performance.

Authors:  Fleur C Garton; Peter J Houweling; Damjan Vukcevic; Lyra R Meehan; Fiona X Z Lee; Monkol Lek; Kelly N Roeszler; Marshall W Hogarth; Chrystal F Tiong; Diana Zannino; Nan Yang; Stephen Leslie; Paul Gregorevic; Stewart I Head; Jane T Seto; Kathryn N North
Journal:  Am J Hum Genet       Date:  2018-04-26       Impact factor: 11.025

7.  Gene expression and genetic variation in human atria.

Authors:  Honghuang Lin; Elena V Dolmatova; Michael P Morley; Kathryn L Lunetta; David D McManus; Jared W Magnani; Kenneth B Margulies; Hakon Hakonarson; Federica del Monte; Emelia J Benjamin; Thomas P Cappola; Patrick T Ellinor
Journal:  Heart Rhythm       Date:  2013-10-28       Impact factor: 6.343

8.  Low intrinsic running capacity is associated with reduced skeletal muscle substrate oxidation and lower mitochondrial content in white skeletal muscle.

Authors:  Donato A Rivas; Sarah J Lessard; Misato Saito; Anna M Friedhuber; Lauren G Koch; Steven L Britton; Ben B Yaspelkis; John A Hawley
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-01-26       Impact factor: 3.619

Review 9.  Cardiac Z-disc signaling network.

Authors:  Derk Frank; Norbert Frey
Journal:  J Biol Chem       Date:  2011-01-21       Impact factor: 5.157

10.  ACTN3 genotype influences muscle performance through the regulation of calcineurin signaling.

Authors:  Jane T Seto; Kate G R Quinlan; Monkol Lek; Xi Fiona Zheng; Fleur Garton; Daniel G MacArthur; Marshall W Hogarth; Peter J Houweling; Paul Gregorevic; Nigel Turner; Gregory J Cooney; Nan Yang; Kathryn N North
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.